Cinryze Disease Interactions
There is 1 disease interaction with Cinryze (C1 esterase inhibitor (human)).
C1 esterase inhibitor, human (applies to Cinryze) thromboembolic events
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: History - Thrombotic/Thromboembolic Disorder
Serious arterial and venous thromboembolic (TE) events have been reported at the recommended dose of C1 Esterase Inhibitor (Human) products. Benefits of C1 Esterase Inhibitor (Human) products for routine prophylaxis of hereditary angioedema attacks should be weighed against the risks of TE events in patients with underlying risk factors. It is recommended to monitor patients with known risk factors for thrombotic events.
Switch to professional interaction data
Cinryze drug interactions
There are 51 drug interactions with Cinryze (C1 esterase inhibitor (human)).
Report options
More about Cinryze (C1 esterase inhibitor (human))
- Cinryze consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
